James Gilligan
President bij TRYPTAMINE THERAPEUTICS LIMITED
Vermogen: - $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Agnes Olszewski | M | 67 | 22 jaar | |
| James Kuo | M | 58 | 5 jaar | |
| Peter Molloy | M | 52 | 4 jaar | |
| Gage Jull | M | 64 | 4 jaar | |
| Sidney Taubenfeld | M | - | 2 jaar | |
| David S. Krause | M | - |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 14 jaar |
| Michael Silverman | M | - | - | |
| Christopher Ntoumenopoulos | M | - | 2 jaar | |
| Peter Guzzo | M | - | 4 jaar | |
| James O’Neill | M | 64 | 2 jaar | |
| Jason Carroll | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Garner William | M | 58 | 3 jaar | |
| Gregory M. McKee | M | 60 | 1 jaar | |
| Dave Tousley | M | 69 | 1 jaar | |
| Don Soland | M | 65 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| George R. Maurer | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 5 jaar |
| Nicholas LaBella | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 3 jaar |
| Terese Gieselman | F | 62 | 1 jaar | |
| Thomas D'Orazio | M | - | - | |
| Luke Hayes | M | - | - | |
| Lawrence Woo | M | - | - | |
| Joy Willis | F | - | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Canada | 16 | 72.73% |
| Verenigde Staten | 6 | 27.27% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- James Gilligan
- Persoonlijk netwerk
